Strategic alliances and the rate of new product development: An empirical study of entrepreneurial biotechnology firms

Deeds, David; Hill, Charles W. L.

doi:10.1016/0883-9026(95)00087-9

Cited by 629 publications

(470 citation statements)

References 13 publications

Supporting

Mentioning

445

Contrasting

Unclassified

Order By: Relevance

“…Thus there should b a positive relationship between TPC and NBF. However, as already stated, Deeds and Hill 13 have found that although initially the relationship could be positive, at some point it may result in diminishing returns or even negative returns. Two main reasons support such a hypothesis:…”

Section: Hypothesis Developmentmentioning

confidence: 79%

“…The paper is based on the previous work of Deeds and Hill, 13 Rothaermel [14][15][16] and Rothaermel and Deeds. 17 These authors have analysed the biopharmaceutical industry in the USA.…”

Section: Fundamental Benefitsmentioning

confidence: 99%

“…In this sense, the faster a firm develops new products and brings them to market, the more likely it is to capture first-mover advantages. 13 It is suggested that strategic alliances are an effective and quick mechanism to integrate all the complementary assets needed to develop a new product. The latter suggests that strategic alliance is the mechanism for the 'symbiotic coexistence' between TPCs and NBFs because of their positive contribution to the rate of new product development.…”

Section: Fundamental Benefitsmentioning

confidence: 99%

“…Our hypotheses are built on the groundwork of the previous research of Deeds and Hill, 13 and Rothaermel and Deeds. 17 All these studies test how the North American biopharmaceutical start-ups have survived entering strategic alliances with incumbents, in order to develop new products more quickly and to gain firstmover advantage.…”

Section: Hypothesis Developmentmentioning

confidence: 99%

See 3 more Smart Citations

Strategic alliances as a mechanism for wealth creation in the biopharmaceutical industry: An empirical analysis of the Spanish case

VÃ¡zquez¹,

MartÃn²,

MascareÃ±as³

2006

JCB

View full text Add to dashboard Cite

The paper studies strategic alliances signed between traditional pharmaceutical companies (TPCs) and new biotechnology firms (NBFs) in Spain, on the initial basis that a firm's rate of new product development is a positive function of the number of strategic alliances that it has entered into. Nevertheless, we believe, as do others, that although strategic alliances may initially have positive effects on that rate, this relationship may exhibit diminishing returns. We suggest that the relationship between the number of alliances and the rate of new product development may be an inverted U-shape in the Spanish biopharmaceutical industry. Our regression model provides evidence to support such a relationship. However, the results suggest that only when the firm enters into too many alliances does diminishing return and ultimately negative return set in. The main strategic conclusion for the biopharmaceutical industry is that alliances represent a viable way for biopharmaceutical companies to gain access to the complementary assets required to increase their rate of new product development. A major contribution to this investigation is the empirical assessment for the Spanish biopharmaceutical industry.

show abstract

Section: Hypothesis Developmentmentioning

confidence: 79%

“…The paper is based on the previous work of Deeds and Hill, 13 Rothaermel [14][15][16] and Rothaermel and Deeds. 17 These authors have analysed the biopharmaceutical industry in the USA.…”

Section: Fundamental Benefitsmentioning

confidence: 99%

Section: Fundamental Benefitsmentioning

confidence: 99%

Section: Hypothesis Developmentmentioning

confidence: 99%

See 2 more Smart Citations

Strategic alliances as a mechanism for wealth creation in the biopharmaceutical industry: An empirical analysis of the Spanish case

VÃ¡zquez¹,

MartÃn²,

MascareÃ±as³

2006

JCB

View full text Add to dashboard Cite

show abstract

“…Alliance performance is measured in a various ways such as alliance sustainability (Beamish, 1987), profits generated from alliance (Reuer & Miller, 1997), and achievement of new product development goal by alliance (Deeds & Hill, 1996). Some researchers go further to measure alliance success using proxies such as stock value increase (Kale, Dyer, & Singh, 2002;Kohers & Kohers, 2000).…”

Section: Methodsmentioning

confidence: 99%

The Comparative Effects of Transaction Cost Economics and Resource Based View: A Technological Alliance Motivational Perspective

Kim¹

2016

IJBSR

View full text Add to dashboard Cite

This paper examines the impact of two main alliance motivation theories, transaction cost economics (TCE) and resource based view (RBV), on alliance processes among Korean manufacturing high-tech ventures. Results show that TCE and RBV are complimentarily explaining the formation of inter-firm alliances. TCE variables are more related with alliance partner characteristics while RBV is more linked with partner capabilities. Both show positive effects on performance. No significant effect is found on determining an alliance governance structure. While selecting appropriate technological alliance partners show positive effects on performance, no significant effect is found between alliance governance structure and performance. Factors of both theories impacting each alliance stage and analytical explanations of such impacts are discussed.

show abstract

The impact of stocks and flows of organizational knowledge on firm performance: an empirical investigation of the biotechnology industry

1999

Self Cite

View full text Add to dashboard Cite

The knowledge‐based view of the firm is a recent approach to understanding the relationship between firm capabilities and firm performance. Specifically, this approach suggests that knowledge generation, accumulation and application may be the source of superior performance. Other research has conceptualized organizational knowledge in terms of stocks of accumulated knowledge in the firm and flows of knowledge into the firm. This paper tests the relationship between stocks and flows of organizational knowledge and firm performance in the biotechnology industry. We suggest that a firm’s geographic location, alliances with other institutions and organizations and R&D expenditures are representative of knowledge flows, while products in the pipeline, firm citations and patents are indicative of knowledge stocks. Through factor analysis, we develop an aggregated measure of location from several variables. A regression model suggests that location is a significant predictor of firm performance as are products in the pipeline and firm citations. A major contribution of this investigation is the operationalization of geographic location and its statistically significant link to firm performance. Copyright © 1999 John Wiley & Sons, Ltd.

show abstract

Strategic alliances and the rate of new product development: An empirical study of entrepreneurial biotechnology firms

Cited by 629 publications

References 13 publications

Strategic alliances as a mechanism for wealth creation in the biopharmaceutical industry: An empirical analysis of the Spanish case

Strategic alliances as a mechanism for wealth creation in the biopharmaceutical industry: An empirical analysis of the Spanish case

The Comparative Effects of Transaction Cost Economics and Resource Based View: A Technological Alliance Motivational Perspective

The impact of stocks and flows of organizational knowledge on firm performance: an empirical investigation of the biotechnology industry

Contact Info

Product

Resources

About